Alterity Therapeutics (ATHE) Expands Phase 2 Clinical Development Program ATH434

Enter Wall Street with StreetInsider Premium. Claim your 1-week free trial here. Alterity Therapeutics (NASDAQ: ATHE), a biotechnology company dedicated to the development of disease-modifying therapies for neurodegenerative conditions, today announced the expansion of the clinical development program of the Company’s core asset, ATH434, in patients with multisystem atrophy (MSA), …

Read More »

American Cancer Society Launches First Cohort of Health System Screening Interventions with Over 50 Facilities, Part of National Return to Screening Initiative

The organization will work with health system partners to develop innovative practices to increase screening and reduce cancer disparities Posted: October 19, 2021, 3:47 p.m. EDT|Update: 46 minutes ago INDIANAPOLIS, October 19, 2021 / PRNewswire / – The American Cancer Society (ACS) announced a partnership with HealthLinc to improve colorectal …

Read More »

A peer-reviewed article confirms that Qualigen’s FastPack® is

CARLSBAD, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) – Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with orphan drug designation potential, announces today the publication of a study in the open source peer-reviewed journal, Diagnostic, validating the FastPack of the Company’s …

Read More »